ライフサイエンスコーパス: cell adhesion molecule-1

1 PF-00547659 (anti-mucosal vascular addressin cell adhesion molecule 1).

2 g with soluble and immobilized intercellular cell adhesion molecule 1.

3 ate antigen 4 binding to its ligand vascular cell adhesion molecule 1.

4 for the vascular marker platelet endothelial cell adhesion molecule 1.

5 leukin 1beta, interferon gamma, and vascular cell adhesion molecule 1.

6 Ox40 and carcinoembryonic antigen-associated cell adhesion molecule 1.

7 ercellular adhesion molecule 1, and vascular cell adhesion molecule 1.

8 lial activation, angiopoietin 2 and vascular cell adhesion molecule 1.

9 ring within focal adhesive sites on vascular cell adhesion molecule-1.

10 monocyte chemotactic protein-1, and vascular cell adhesion molecule-1.

11 rosis factor-mediated expression of vascular cell adhesion molecule-1.

12 cle cell actin and up-regulation of vascular cell adhesion molecule-1.

13 IL-6, serum amyloid P, and soluble vascular cell adhesion molecule-1.

14 de mimicking monocyte engagement by vascular cell adhesion molecule-1.

15 tic peptide (NT-proBNP) and soluble vascular cell adhesion molecule-1.

16 gen-4 (VLA-4), which interacts with vascular cell adhesion molecule-1.

17 hannels and also B cell adhesion to vascular cell adhesion molecule-1.

18 1 and loss of binding to its ligand vascular cell adhesion molecule-1.

19 ] vs. 1.66 [1.22-2.63] p < 0.0001), vascular cell adhesion molecule 1 (539 [451-621] vs. 402 [342-487

20 tein-1 (-13% versus +0.2%), soluble vascular cell adhesion molecule-1 (-6% versus +1%), high-sensitiv

21 Tumour necrosis factor alpha, vascular cell adhesion molecule-1, 8-isoprostane, leptin, circula

22 of CEACAM1 (carcinoembryonic antigen-related cell adhesion molecule 1), a transmembrane glycoprotein

23 CpG-induced calcium signals and vascular cell adhesion molecule-1 adhesion are TLR9-independent a

24 tory proteins, cyclooxygenase-2 and vascular cell adhesion molecule-1 also in an Src kinase family-de

25 Vascular cell adhesion molecule 1, an adhesion molecule that medi

26 ed monocyte adhesion by attenuating vascular cell adhesion molecule -1 and monocyte chemoattractant p

27 hesion to their respective ligands, vascular cell adhesion molecule 1 and intercellular adhesion mole

28 k of vessels expressing platelet/endothelial cell adhesion molecule 1 and vascular endothelial growth

29 their respective ligands, mucosal addressin cell adhesion molecule-1 and CCL25, are displayed on end

30 d firm arrest of mouse monocytes on vascular cell adhesion molecule-1 and E-selectin in a shear flow

31 g in increased adhesion to mucosal addressin cell adhesion molecule-1 and enhanced homing to Peyer's

32 ls adhere to high concentrations of vascular cell adhesion molecule-1 and intercellular adhesion mole

33 ecreased collar-induced endothelial vascular cell adhesion molecule-1 and intercellular adhesion mole

34 vels and inhibited cytokine-induced vascular cell adhesion molecule-1 and intercellular adhesion mole

35 ice showed significant decreases in vascular cell adhesion molecule-1 and intercellular adhesion mole

36 In addition, CLP-increased vascular cell adhesion molecule-1 and intercellular adhesion mole

37 e blocking effect of kallistatin on vascular cell adhesion molecule-1 and monocyte chemoattractant pr

38 ed NF-kappaB activation, as well as vascular cell adhesion molecule-1 and monocyte chemoattractant pr

39 and increased plasma levels of intercellular cell adhesion molecule-1 and monocyte chemoattractant pr

40 and plasma adhesion molecules, intercellular cell adhesion molecule-1 and monocyte chemoattractant pr

41 for inflammatory mediators such as vascular cell adhesion molecule-1 and monocyte chemotactic protei

42 he expression of adhesion molecules vascular cell adhesion molecule-1 and monocyte chemotactic protei

43 Whereas vascular cell adhesion molecule-1 and P-selectin were not require

44 ascular adhesion molecules, such as vascular cell adhesion molecule-1 and platelet endothelial cell a

45 nd endothelial dysfunction (soluble vascular cell adhesion molecule-1 and soluble intercellular adhes

46 ted adhesion of proerythroblasts to Vascular Cell Adhesion Molecule-1 and the fibronectin spliceoform

47 ination by increasing expression of vascular cell adhesion molecule-1 and the transcytosis protein Ca

48 overy in the absence of platelet endothelial cell adhesion molecule-1 and the tyrosine phosphatase CD

49 s interactions with both macrophage Vascular Cell Adhesion Molecule-1 and with extracellular matrix f

50 mor necrosis factor alpha receptor, vascular cell adhesion molecule 1, and matrix metalloproteinase 2

51 rkers (CD34, endomucin, platelet endothelial cell adhesion molecule 1, and plasmalemmal vesicle-assoc

52 intercellular adhesion molecule 1, vascular cell adhesion molecule 1, and tissue factor messenger RN

53 e measured levels of hsCRP, ICAM-1, vascular cell adhesion molecule 1, and tumor necrosis factor alph

54 intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin expressions are

55 intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin.

56 intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and leptin and decreased inter

57 igh-mobility group protein B1, intracellular cell adhesion molecule-1, and leptin, as well as previou

58 intracellular adhesion molecule-1, vascular cell adhesion molecule-1, and monocyte chemotactic prote

59 sion molecule (VCAM)-1, platelet-endothelial cell adhesion molecule-1, and P-selectin and L-selectin

60 tercellular adhesion molecule-1 and vascular cell adhesion molecule-1, and VEDS probands had abnormal

61 function blocking anti-platelet endothelial cell adhesion molecule 1 antibody, depolymerizing microt

62 s vascular ligand mucosal vascular addressin cell adhesion molecule 1 are proving the value of lympho

63 Here, we identify vascular cell adhesion molecule 1 as the relevant receptor for ly

64 ds to reduced levels of platelet endothelial cell adhesion molecule-1 at the cell surface.

65 ted adhesion of proerythroblasts to Vascular Cell Adhesion Molecule-1 but not to the fibronectin spli

66 12% (95% CI, -14% to -10%), soluble vascular cell adhesion molecule-1 by 14% (95% CI, -18% to -10%),

67 tercellular adhesion molecule-1 and vascular cell adhesion molecule-1 by, and adhesion of human eosin

68 Human carcinoembryonic antigen-related cell adhesion molecule 1 (C?/Au: EACAM1) is a cell-surfa

69 ns between body mass index and two loci near cell adhesion molecule 1 (CADM1) and cell adhesion molec

70 set, only single nucleotide polymorphisms in cell adhesion molecule 1 (CADM1) associated with VT.

71 says to establish that the tumour suppressor Cell adhesion molecule 1 (CADM1) inhibits SqCC prolifera

72 pon activation, whereas the ligand of Crtam, cell adhesion molecule 1 (Cadm1), is expressed on gut CD

73 neutralization of stem cell factor (SCF) or cell adhesion molecule 1 (CADM1).

74 We have investigated the role of cell adhesion molecule 1 (Cadm1; Necl2) in this disease.

75 partially dependent on adhesion mediated by cell adhesion molecule-1 (CADM1), but the adhesion mecha

76 -1 increased eosinophil adhesion to vascular cell adhesion molecule-1, caused redistribution of integ

77 ecreased expressions of platelet endothelial cell adhesion molecule-1/CD-31, vascular endothelial gro

78 lar adhesion molecule 2 (CD102) and vascular cell adhesion molecule 1 (CD106).

79 A1, we detected reduced platelet endothelial cell adhesion molecule 1 (CD31) and increased endothelia

80 ine kinase 7 (PTK7) and platelet endothelial cell adhesion molecule-1 (CD31).

81 The carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) can engage in both ci

82 hough carcinoembryonic antigen (CEA)-related cell adhesion molecule 1 (CEACAM1) has been viewed as a

83 ole for the carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) in the regulation of

84 The carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) is a transmembrane gl

85 Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) is expressed at high

86 Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) promotes hepatic insu

87 Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) regulates insulin sen

88 a heterodimer with carcinoembryonic antigen cell adhesion molecule 1 (CEACAM1), another well-known m

89 ptor murine carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1), which surprisingly r

90 on molecule carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1-S) in which G-actin bi

91 Although carcinoembryonic antigen-related cell adhesion molecule-1 (CEACAM1) is an activation mark

92 Carcinoembryonic antigen-related cell adhesion molecule-1 (CEACAM1) is expressed in a var

93 Carcinoembryonic antigen-related cell adhesion molecule-1 (CEACAM1), a transmembrane prot

94 thelial activation markers (soluble vascular cell adhesion molecule-1) decreased but remained elevate

95 tercellular adhesion molecule 1 and vascular cell adhesion molecule 1, disruption or loosening of adh

96 tercellular adhesion molecule-1 and vascular cell adhesion molecule-1, disruption or loosening of adh

97 Neurons that lack Drosophila Down syndrome cell adhesion molecule 1 (Dscam1) show aberrant overlap,

98 ased aPL-induced expression of intercellular cell adhesion molecule-1, E-selectin, and tissue factor

99 intercellular adhesion molecule-1, vascular cell adhesion molecule-1, endothelial selectin, and angi

100 y important regulatory proteins, endothelial cell adhesion molecule 1 (ESAM1) and cadherin 5 (CDH5),

101 e posttranscriptional regulation of vascular cell adhesion molecule 1 expression and a reduced number

102 ted with a marked reduction in lung vascular cell adhesion molecule 1 expression and production of se

103 dhesion molecule 1, and platelet endothelial cell adhesion molecule 1 expression when stimulated with

104 ow detectable levels of platelet endothelial cell adhesion molecule 1 expression, and in rat tissue,

105 criptional activity and upregulated vascular cell adhesion molecule 1 expression.

106 markers, and carotid P-selectin and vascular cell adhesion molecule-1 expression by contrast-enhanced

107 Furthermore, vascular cell adhesion molecule-1 expression in both mouse and hu

108 uperoxide production, and increased vascular cell adhesion molecule-1 expression in human aortic endo

109 y, CPAP-30 and STEP-30/30 increased vascular cell adhesion molecule-1 expression, but the type of rec

110 thelial ROS production, endothelial vascular cell adhesion molecule-1 expression, matrix metalloprote

111 was associated with an increase in vascular cell adhesion molecule-1 expression, which itself was re

112 d with beta-blocker showed enhanced vascular cell adhesion molecule-1 expression.

113 sphorylated beta-catenin stimulates vascular cell-adhesion molecule-1 expression to increase EC-monoc

114 ed strong CD31/PECAM-1 (platelet endothelial cell adhesion molecule 1) expression by neoplastic cells

115 density lipoprotein uptake, VCAM-1 (vascular cell adhesion molecule 1) expression, apoptosis, and inc

116 tracellular adhesion molecule 1 and vascular cell adhesion molecule 1) genes involved in myeloid cell

117 necrosis factor receptor-1, soluble vascular cell adhesion molecule-1, granulocyte colony-stimulating

118 , and induced up-regulation of intercellular cell adhesion molecule-1, HLA-DR, and CD40 by primary ep

119 , and ultimately for promoting intracellular cell adhesion molecule 1 (ICAM-1) binding.

120 sion by T cells, chemokine and intracellular cell adhesion molecule 1 (ICAM-1) expression in the brai

121 various methods, we found that intercellular cell adhesion molecule 1 (ICAM-1) was reduced in Lec9 ce

122 ulates the lateral mobility of intracellular cell adhesion molecule 1 (ICAM-1), but not MHCII.

123 (ie, ET-1, ET-A and ET-B receptors, vascular cell adhesion molecule-1, IL-6, and fractalkine) is part

124 r RvD1 inhibited the expressions of vascular cell adhesion molecule-1, IL-8, macrophage inflammatory

125 tion of VE-cadherin and platelet endothelial cell adhesion molecule 1, impaired development of baseme

126 cells; IL-4; IL-5; eosinophils, and vascular cell adhesion molecule 1 in the large airways and bronch

127 ocyte chemoattractant protein-1 and vascular cell adhesion molecule 1 in wire-injured carotid arterie

128 dhesion molecule-A, and platelet/endothelial cell adhesion molecule-1 in endothelial cells, increased

129 tores the expression of platelet endothelial cell adhesion molecule-1 in glomerular endothelial cells

130 ncrease in plasma levels of soluble vascular cell adhesion molecule-1 in sickle mice was not mediated

131 l adhesion molecules E-selectin and vascular cell adhesion molecule-1 in the microvasculature of kidn

132 elial nitric oxide, superoxide, and vascular cell adhesion molecule-1 in vitro improved significantly

133 on and enhanced binding to mucosal addressin cell adhesion molecule-1 in vitro while simultaneously s

134 n vitro and increased expression of vascular cell adhesion molecule-1 in vivo.

135 tercellular adhesion molecule-1 and vascular cell adhesion molecule-1) in 524 middle-aged women in th

136 racellular adhesion molecule 1, and vascular cell adhesion molecule 1), increased expression of CB(1)

137 The expression of vascular cell adhesion molecule-1 induced by IgG-APS or 4C5 in ex

138 (intercellular adhesion molecule-1, vascular cell adhesion molecule-1), inducible nitric oxide syntha

139 intercellular adhesion molecule-1, vascular cell adhesion molecule-1, inducible nitric oxide synthas

140 dothelial growth factor receptor-2, vascular cell adhesion molecule 1, intercellular adhesion molecul

141 illebrand factor (VWF), E-selectin, vascular cell adhesion molecule 1, intercellular adhesion molecul

142 wnregulated the local expression of vascular cell adhesion molecule-1, intercellular adhesion molecul

143 asing the expression of E-selectin, vascular cell adhesion molecule-1, intercellular adhesion molecul

144 Plasminogen activator inhibitor 1, vascular cell adhesion molecule-1, intracellular adhesion molecul

145 Platelet-endothelial cell adhesion molecule-1 is a transmembrane protein conn

146 e cell adhesion protein platelet endothelial cell adhesion molecule-1 is dependent on the protein acy

147 pression of 194 genes, such as claudin 3 and cell adhesion molecule 1, is significantly decreased.

148 NF-kappaB activation also induced vascular cell adhesion molecule 1, keratinocyte chemoattractant,

149 nes, leukotriene B(4) (LTB(4)), and vascular cell adhesion molecule 1 levels in the lungs, was reduce

150 , neuron-specific enolase, and intracellular cell adhesion molecule-1 levels did not differ between n

151 derived microparticles, platelet-endothelial cell adhesion molecule-1 lung protein content, and immun

152 ruptions in positioning of mucosal addressin cell adhesion molecule 1 (MAdCAM-1)(+) sinus lining cell

153 rned to display dominantly mucosal addressin cell adhesion molecule 1 (MAdCAM-1).

154 ssion patterns of mucosal vascular addressin cell adhesion molecule-1 (MAdCAM-1) and T cell responses

155 adhesion molecule mucosal vascular addressin cell adhesion molecule-1 (MAdCAM-1) and that RA increase

156 promotes cell adherence to mucosal addressin cell adhesion molecule-1 (MAdCAM-1) expressed by vascula

157 tibody that binds to human mucosal addressin cell adhesion molecule-1 (MAdCAM-1) to selectively reduc

158 al ligand for alpha4beta7, mucosal addressin cell adhesion molecule-1 (MAdCAM-1), bound efficiently t

159 n humans as XCR1(+)CD141 (BDCA-3)(+)Clec9A(+)cell adhesion molecule 1(+) mDC, and in sheep as CD26(+)

160 me-controlled ventilation increased vascular cell adhesion molecule-1 messenger RNA expression (volum

161 ulating levels of immunoglobulin A, vascular cell adhesion molecule-1, myeloperoxidase, and major cyt

162 pendent on Schwann cell expression of neural cell adhesion molecule 1 (NCAM1) and ultimately promoted

163 We also found that miR-200c and neural cell adhesion molecule 1 (NCAM1) expression were negativ

164 rly AMD was associated with soluble vascular cell adhesion molecule-1 (odds ratio per SD on the logar

165 igen) and angiogenesis (platelet endothelial cell adhesion molecule-1 or CD31, vascular endothelial g

166 onic PTSD had a greater increase in vascular cell adhesion molecule-1 over time (B = 0.003, p < .05).

167 the endothelial activation markers vascular cell adhesion molecule 1 (P < .001 for both) and angiopo

168 tercellular adhesion molecule-1 and vascular cell adhesion molecule-1 (P < .05).

169 dhesion molecule-1, E-selectin, and vascular cell adhesion molecule-1 (P < 0.05 above bacterial load

170 ted levels of NT-proBNP and soluble vascular cell adhesion molecule-1 (P< .001).

171 muscle actin, vimentin, platelet endothelial cell adhesion molecule 1 (PECAM), and aquaporin 1, a mar

172 Using platelet endothelial cell adhesion molecule 1 (PECAM-1) as a prototypical ITI

173 ated with antibodies to platelet/endothelial cell adhesion molecule 1 (PECAM-1) bind specifically to

174 regulation of MHC-I and platelet endothelial cell adhesion molecule 1 (PECAM-1) but not other substra

175 steocalcin, Vega-a, and platelet endothelial cell adhesion molecule 1 (PECAM-1) in Fgf-9(+/-) defects

176 Platelet Endothelial Cell Adhesion Molecule 1 (PECAM-1) is a major component

177 Platelet endothelial cell adhesion molecule 1 (PECAM-1) is involved in leukoc

178 on molecule 1 (VCAM-1), platelet-endothelial cell adhesion molecule 1 (PECAM-1), CD99, and interleuki

179 tioning in part through platelet endothelial cell adhesion molecule 1 (PECAM-1), drives advanced meta

180 ntegrins and recognizes platelet endothelial cell adhesion molecule 1 (PECAM-1), suggesting a role in

181 dent firm adhesion, and platelet/endothelial cell adhesion molecule 1 (PECAM-1)-mediated transendothe

182 cells, colocalizes with platelet/endothelial cell adhesion molecule-1 (PECAM) to surround leukocytes

183 ion molecules including Platelet-Endothelial Cell Adhesion Molecule-1 (PECAM-1 or CD31) improves drug

184 Platelet endothelial cell adhesion molecule-1 (PECAM-1) and heterotrimeric G

185 Platelet-endothelial cell adhesion molecule-1 (PECAM-1) and the Src family ki

186 otransducers, including platelet endothelial cell adhesion molecule-1 (PECAM-1) at cell-cell junction

187 shown that endothelial platelet endothelial cell adhesion molecule-1 (PECAM-1) expression is pro-ath

188 a, as well as increased platelet endothelial cell adhesion molecule-1 (PECAM-1) expression, which was

189 Platelet endothelial cell adhesion molecule-1 (PECAM-1) is a 130-kDa member o

190 cule (MCAM)/MUC18, CD31/platelet endothelial cell adhesion molecule-1 (PECAM-1), CD144/VE-cadherin, a

191 One CAM member, platelet-endothelial-cell adhesion molecule-1 (PECAM-1), plays an important r

192 chanosensors, including platelet endothelial cell adhesion molecule-1 (PECAM-1), that convert mechani

193 ion of the shear sensor platelet endothelial cell adhesion molecule-1 (PECAM-1).

194 urface targets like the Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1, a highly expressed en

195 inished inflammation (expression of vascular cell adhesion molecule 1, plaque macrophage content) and

196 adhesion molecule-1 and platelet endothelial cell adhesion molecule-1 post-IRI.

197 the stromal cells and with reduced vascular cell adhesion molecule 1 production by them.

198 cles and a reduction of platelet-endothelial cell adhesion molecule-1 protein levels in the high-tida

199 tercellular adhesion molecule 1 and vascular cell adhesion molecule-1 rather than endothelial cells w

200 ering to culture plates coated with vascular cell adhesion molecule 1, SDF-1 and stem cell factor inc

201 inally associated with soluble intracellular cell adhesion molecule-1 (sICAM-1) (P = 0.026) and TNF-R

202 esion molecule 1 (sICAM-1), soluble vascular cell adhesion molecule 1, soluble E-selectin, and monocy

203 n), and leukocyte adhesion (soluble vascular cell adhesion molecule-1, soluble intracellular adhesion

204 tercellular adhesion molecule-1 and vascular cell adhesion molecule-1 surface expression in BMVECs ex

205 Soluble vascular cell adhesion molecule-1 (sVCAM-1) is a marker of endoth

206 r adhesion molecule-1 (sICAM-1) and vascular cell adhesion molecule-1 (sVCAM-1) were higher following

207 ular adhesion molecule-1 (sICAM-1), vascular cell adhesion molecule-1 (sVCAM-1), E-selectin (sE-Selec

208 zed the synapse-organizing proteins Synaptic Cell Adhesion Molecule 1 (SynCAM 1) and EphB2.

209 for NCAM, neuropilin-2 (NRP-2), and synaptic cell adhesion molecule 1 (SynCAM 1) for polysialylation

210 Among them is synaptic cell adhesion molecule 1 (SynCAM 1), a member of the imm

211 Here we identify that the synaptic cell adhesion molecule 1 (SynCAM 1), an immunoglobulin s

212 lect adhesion molecules such as the Synaptic Cell Adhesion Molecule 1 (SynCAM 1/CADM1/nectin-like 2 p

213 endothelial expression of mucosal addressin cell adhesion molecule-1, the ligand that supports entry

214 eptor 2, interleukin-6, and soluble vascular cell adhesion molecule-1 to the 20-year cumulative incid

215 suggest that lymphocyte binding to vascular cell adhesion molecule 1 triggers a signaling process th

216 (intercellular adhesion molecule-1, vascular cell adhesion molecule-1), tumor necrosis factor-alpha,

217 intercellular adhesion molecule-1, vascular cell adhesion molecule-1, tumor necrosis factor-alpha, a

218 including VE-cadherin, platelet endothelial cell adhesion molecule 1, type IV collagen, matrix metal

219 dramatically increased platelet-endothelial cell adhesion molecule 1 tyrosine phosphorylation and di

220 tercellular adhesion molecule 1 and vascular cell adhesion molecule 1 under the migrating leukocyte,

221 ess to alpha4beta1 integrin ligands vascular cell adhesion molecule 1 (VCAM-1) and fibronectin, where

222 The levels of soluble vascular cell adhesion molecule 1 (VCAM-1) and osteoprotegerin we

223 vealed that the interaction between vascular cell adhesion molecule 1 (VCAM-1) and very late antigen-

224 Vascular cell adhesion molecule 1 (VCAM-1) expression, however, w

225 ar adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) in the lungs of infect

226 raction with the endothelial ligand vascular cell adhesion molecule 1 (VCAM-1) may also play a role i

227 ils adhering to surfaces expressing vascular cell adhesion molecule 1 (VCAM-1) motivated the developm

228 Vascular cell adhesion molecule 1 (VCAM-1) plays a major role in

229 cyte recruitment through binding to vascular cell adhesion molecule 1 (VCAM-1) upregulated on inflame

230 lical vein endothelial cell (HUVEC) vascular cell adhesion molecule 1 (VCAM-1) upregulation.

231 Levels of vascular cell adhesion molecule 1 (VCAM-1) were measured by sandw

232 Here, we show that red pulp vascular cell adhesion molecule 1 (VCAM-1)(+) macrophages are ess

233 as an adhesive ligand that captures vascular cell adhesion molecule 1 (VCAM-1)(+) metastatic tumor ce

234 d antibody (pro-antibody) targeting vascular cell adhesion molecule 1 (VCAM-1), a marker of atheroscl

235 ctic protein 1 (MCP-1), IL-6, IL-8, vascular cell adhesion molecule 1 (VCAM-1), and E-selectin were e

236 pression of an inflammatory marker, vascular cell adhesion molecule 1 (VCAM-1), in atherosclerotic pl

237 adherence to endothelium, including vascular cell adhesion molecule 1 (VCAM-1), intercellular adhesio

238 lular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), platelet-endothelial

239 ent directed against mouse or human vascular cell adhesion molecule 1 (VCAM-1), recently has been pro

240 chemoattractant protein 1 (MCP-1), vascular cell adhesion molecule 1 (VCAM-1), secretory phospholipa

241 les, including the level of soluble vascular cell adhesion molecule 1 (VCAM-1), were assessed at the

242 llular adhesion molecule 1 (ICAM-1)/vascular cell adhesion molecule 1 (VCAM-1)-mediated adhesion of b

243 as specific for L-selectin, because vascular cell adhesion molecule 1 (VCAM-1)-mediated adhesion was

244 ve behavioral outcomes, and a novel vascular cell adhesion molecule 1 (VCAM-1)-targeted magnetic reso

245 ion molecules (ELAM) E-selectin and vascular cell adhesion molecule 1 (VCAM-1).

246 ar adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1).

247 Vascular cell adhesion molecule 1 (VCAM-1; CD106), a member of th

248 In vivo molecular imaging of vascular cell adhesion molecule-1 (VCAM 1) P-selectin, and platel

249 p II: 0.14 (0.20) mug/mL, P = .02); vascular cell adhesion molecule-1 (VCAM-1) (Group I: 0.34 (0.67)

250 Binding of leukocytes to vascular cell adhesion molecule-1 (VCAM-1) activates signals in e

251 bition of TNF-induced expression of vascular cell adhesion molecule-1 (VCAM-1) and could be mimicked

252 an PDEs of the endothelial proteins vascular cell adhesion molecule-1 (VCAM-1) and endothelial nitric

253 ing that controls expression of the vascular cell adhesion molecule-1 (VCAM-1) and monocyte adhesion

254 ll as expression of redox-sensitive vascular cell adhesion molecule-1 (VCAM-1) and monocyte chemotact

255 the endothelial activation markers vascular cell adhesion molecule-1 (VCAM-1) and vascular adhesion

256 ished by CD29 blockade on hMSCs and vascular cell adhesion molecule-1 (VCAM-1) blockade on HSECs.

257 ar adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) expression by redox-de

258 treatment induced up-regulation of vascular cell adhesion molecule-1 (VCAM-1) expression in a PKCeps

259 p38 MAPK-dependent while increased vascular cell adhesion molecule-1 (VCAM-1) expression was NF-kapp

260 Vascular cell adhesion molecule-1 (VCAM-1) expression was notable

261 lammation was used to induce global vascular cell adhesion molecule-1 (VCAM-1) expression.

262 o transiently augmented LPS-induced vascular cell adhesion molecule-1 (VCAM-1) expression.

263 l presents additional evidence that vascular cell adhesion molecule-1 (VCAM-1) imaging in atheroscler

264 target genes tissue factor (TF) and vascular cell adhesion molecule-1 (VCAM-1) in diabetic apoE(-/-)h

265 enesis, but increased expression of vascular cell adhesion molecule-1 (VCAM-1) in primary culture of

266 Vascular cell adhesion molecule-1 (VCAM-1) is a cell surface rece

267 Vascular cell adhesion molecule-1 (VCAM-1) is expressed on the me

268 Vascular cell adhesion molecule-1 (VCAM-1) plays important roles

269 lular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and E-selectin, resul

270 chemoattractant protein-1 (MCP-1), vascular cell adhesion molecule-1 (VCAM-1), nuclear factor kappaB

271 subsequent induction of endothelial vascular cell adhesion molecule-1 (VCAM-1), which is required for

272 y late antigen-4 (VLA-4) binding to vascular cell adhesion molecule-1 (VCAM-1), which is upregulated

273 onsequence of reduced expression of vascular cell adhesion molecule-1 (VCAM-1), which regulates leuko

274 in-1 (MCP-1) and 36% lower lesional vascular cell adhesion molecule-1 (VCAM-1).

275 underwent firm adhesion mediated by vascular cell adhesion molecule-1 (VCAM-1).

276 that enables imaging of endothelial vascular cell adhesion molecule-1 (VCAM-1).

277 ry activation involving exposure of vascular cell adhesion molecule-1 (VCAM-1).

278 ar adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1).

279 ar adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1).

280 ar adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1).

281 kines, and cell adhesion molecules (vascular cell adhesion molecule 1 [VCAM-1] and intracellular adhe

282 ibitor of metalloproteinases 1; and vascular cell adhesion molecule 1 [VCAM-1]) were measured by usin

283 ellular adhesion molecule 1 (ICAM1)/vascular cell adhesion molecule 1 (VCAM1), whose expression was a

284 of the proinflammatory cell surface vascular cell adhesion molecule 1 (VCAM1).

285 , which was reversed by blockade of vascular cell adhesion molecule-1 (VCAM1) and very late antigen-4

286 Vascular cell adhesion molecule-1 (VCAM1) constitutes a relevant

287 the adhesion and signaling molecule vascular cell adhesion molecule-1 (VCAM1).

288 responsive genes, but expression of vascular cell-adhesion molecule-1 (Vcam1) was particularly high.

289 r endothelial growth factor [VEGF], vascular cell adhesion molecule 1 [VCAM1], and GTP binding protei

290 Although vascular cell adhesion molecule-1 (VLA-4 receptor) was expressed

291 cle cell actin, and upregulation of vascular cell adhesion molecule-1 was also suppressed in FLAP kno

292 ercellular adhesion molecule 1, and vascular cell adhesion molecule 1) was slightly up- or down-regul

293 le, CD31, also known as platelet endothelial cell adhesion molecule-1, was sialylated via alpha2,6-li

294 esion receptor PECAM-1 (platelet endothelial cell adhesion molecule-1), we investigated a potential c

295 lar adhesion molecule 1 and soluble vascular cell adhesion molecule 1 were reduced after whey protein

296 ocyte chemoattractant protein-1 and vascular cell adhesion molecule-1 were reduced.

297 tracellular adhesion molecule-1 and vascular cell adhesion molecule-1, which caused a fourfold increa

298 oparticles positive for platelet-endothelial cell adhesion molecule-1, which could serve as potential

299 monocytes sheared in whole blood on vascular cell adhesion molecule-1, while characterizing adhesion

300 O], matrix metalloproteinase 9, and vascular cell adhesion molecule 1) would be increased and associa